NEW YORK, March 15, 2007 -- On Monday, March 26, The Biotechnology Study Center of NYU School of Medicine will hold its annual awards symposium to honor three outstanding pioneers in biomedical research. The Dart/NYU Biotechnology Achievement Awards recognize the role of pure science in the development of pharmaceuticals, and particularly honor those scientists whose work has led to major advances at the bedside. A traditional Steuben glass sculpture and honorarium accompanies each award.
The 2007 awards will be given to Joan V. Ruderman, who has elucidated the most basic of life processes: the cell division cycle; Salvador Moncada for his discovery that nitric oxide is both the target and effector of a score of compounds now in the clinic for the treatment of cardiovascular and rheumatic diseases; and Charles N. Serhan for leading a worldwide effort to discover new chemical signals that control inflammation and its resolution.
These distinguished medical researchers will receive their awards at a ceremony to be held at 4:00 p.m. in Schwartz Lecture Hall F at NYU School of Medicine. Dr. Gerald Weissmann, Director of the Biotechnology Study Center, will chair the symposium, which will be co-sponsored by The Honors Program and feature presentations by each of the awardees.
The ceremony will be followed by a public reception in the Faculty Dining Room. Since 2004, the awards have been aided by a generous grant from Dart Neuroscience LLP and are awarded on behalf of the Fellows of the Center.
THE AWARD RECIPIENTS
In Basic Biotechnology: Joan V. Ruderman (Marion V. Nelson Professor of Cell Biology at the Harvard Medical School)
Dr. Rudermans work has elucidated the most basic of life processes: the cell division cycle. Her early work, carried out mainly with eggs of clams, sea urchins and frogs, led to a breakthrough in our understanding of how two types of proteins, cyclins and the cyc
Contact: Pamela McDonnell
New York University Medical Center and School of Medicine